Elanco

Animal Wound Care Market worth $1.7 billion by 2027 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Monday, August 8, 2022
Knowledge, Intelligence, Burn, Pump, SME, A/S, Growth, LLC, Companion, Research, Elanco, 3D ultrasound, Niece and nephew, Surgery, Consumables, GEM, Ethicon Inc., Diabetic foot, Medtronic, Gynaecology, CAGR, Dechra Pharmaceuticals, Hospital, Ulcer, Animal, Monitoring, USD, Pet, Medical device, Marketing, Anesthesia, Diagnosis

CHICAGO, Aug. 8, 2022 /PRNewswire/ -- Animal Wound Care Market is projected to grow from USD 1.2 billion in 2022 to USD 1.7 billion by 2027, at a CAGR of 7.3% from 2022 to 2027, according to a new report by MarketsandMarkets.

Key Points: 
  • CHICAGO, Aug. 8, 2022 /PRNewswire/ -- Animal Wound Care Market is projected to grow from USD 1.2 billion in 2022 to USD 1.7 billion by 2027, at a CAGR of 7.3% from 2022 to 2027, according to a new report by MarketsandMarkets.
  • The growth in this market is driven by rising demand for animal food products, increasing companion animal market, and surging veterinary healthcare expenditure.
  • In this report, the animal wound care market is segmented on the basis of product, animal type, end users and region.
  • On the basis of region, the animal wound care market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East Africa.

Animal Wound Care Market worth $1.7 billion by 2027 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Monday, August 8, 2022
Knowledge, Intelligence, Burn, Pump, SME, A/S, Growth, LLC, Companion, Research, Elanco, 3D ultrasound, Niece and nephew, Surgery, Consumables, GEM, Ethicon Inc., Diabetic foot, Medtronic, Gynaecology, CAGR, Dechra Pharmaceuticals, Hospital, Ulcer, Animal, Monitoring, USD, Pet, Medical device, Marketing, Anesthesia, Diagnosis

CHICAGO, Aug. 8, 2022 /PRNewswire/ -- Animal Wound Care Market is projected to grow from USD 1.2 billion in 2022 to USD 1.7 billion by 2027, at a CAGR of 7.3% from 2022 to 2027, according to a new report by MarketsandMarkets.

Key Points: 
  • CHICAGO, Aug. 8, 2022 /PRNewswire/ -- Animal Wound Care Market is projected to grow from USD 1.2 billion in 2022 to USD 1.7 billion by 2027, at a CAGR of 7.3% from 2022 to 2027, according to a new report by MarketsandMarkets.
  • The growth in this market is driven by rising demand for animal food products, increasing companion animal market, and surging veterinary healthcare expenditure.
  • In this report, the animal wound care market is segmented on the basis of product, animal type, end users and region.
  • On the basis of region, the animal wound care market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East Africa.

Europe Dog Dewormers Market Report 2022: Featuring Key Players Merck & Co, Boehringer Ingelheim, Virbac, Elanco, Ceva, Zoetis, PetIQ & Sava Healthcare - ResearchAndMarkets.com

Retrieved on: 
Wednesday, July 20, 2022
Veterinary, Health, Chapter Five, Audubon Manning Veterinary Clinic (AMVC), EUR, Probiotic, Ownership, USD, PETS, Chapter Three, Chapter Four, Adoption, CAGR, Country, Market share, Annual report, Distribution, Dog, Retail, Pet, Elanco

Europe's dog dewormers market size is expected to reach USD 793.2 million by 2030.

Key Points: 
  • Europe's dog dewormers market size is expected to reach USD 793.2 million by 2030.
  • The rising canine population along with their ownership and growing expenditure on dogs are major factors propelling the market growth.
  • The European market for dog dewormers is expected to grow notably in the coming years.
  • Chapter 3 Europe Dog Dewormers Market Variables, Trends & Scope
    Chapter 4 Europe Dog Dewormers Market: Segment Analysis, By Distribution Channel, 2017-2030 (USD Million)
    Chapter 5 Europe Dog Dewormers Market: Country Market Analysis 2017-2030 (USD Million)

Elanco Confirms Date and Conference Call for Second Quarter 2022 Financial Results Announcement

Retrieved on: 
Monday, July 18, 2022
Health, Consumer, Agriculture, Pets, Natural Resources, Veterinary, Health, Farmer, Interpersonal relationship, NYSE, Disease, PETS, ELAN, Animal, Veterinarian, Elanco, Food

Elanco Animal Health Incorporated (NYSE: ELAN) will announce its second quarter 2022 financial results on Monday, August 8, 2022.

Key Points: 
  • Elanco Animal Health Incorporated (NYSE: ELAN) will announce its second quarter 2022 financial results on Monday, August 8, 2022.
  • Elanco will also conduct a conference call on that day with the investment community and media to further detail the companys performance.
  • The conference call will begin at 8:00 a.m. eastern time.
  • Investors, media, and the general public can access a live webcast of the conference call through the link that will be posted on Elancos website at https://investor.elanco.com/events-and-presentations/default.aspx .

Elanco Survey Finds Many Pets Live Unprotected Against Preventable Diseases

Retrieved on: 
Tuesday, July 12, 2022
General Health, Health, Pets, Consumer, Prevalence, Disease, Infection, Purging disorder, Society, Multimedia, Animal, Vaccine, ASPCA, Leptospirosis, Awareness, Veterinarian, Risk, Gaps, Name, ELAN, Adult, COVID-19, Savanta ComRes, Depression, Interpersonal relationship, PETS, Dog, Symptoms of COVID-19, Soil, Health, Vomiting, NYSE, Pet, Vaccination, Water, Lethargy, Farmer, Parent, Pharmaceutical industry, Lyme disease, Food, Elanco

Amidst a surge of pet adoptions, a new survey released by Elanco finds many pets are insufficiently protected against common diseases like Lyme and leptospirosis.

Key Points: 
  • Amidst a surge of pet adoptions, a new survey released by Elanco finds many pets are insufficiently protected against common diseases like Lyme and leptospirosis.
  • At Elanco, we believe vaccinated pets are the happiest pets.
  • Pets and parents share a unique and loving bond and our goal is to make sure pets live longer, healthier lives.
  • ASPCA Pandemic Pet Ownership Survey Memo, May 2021
    Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates.

Insights on the Beta Agonist Feed Additive Global Market to 2027 - Increasing Demand for Animal Meat to Boost the Beta Agonist Feed Additive Sales - ResearchAndMarkets.com

Retrieved on: 
Friday, July 1, 2022
Agriculture, Natural Resources, Pressure, Lists of countries and territories, USDA, Tyson Foods, Meat, Egg, COVID-19, Population, Urbanization, Schering-Plough, Milk, Elanco, Cattle, CAGR, Gross domestic product, Diet, Environmental impact of meat production, City, Population growth, Income, Poultry, Livestock, Agriculture, Agriculture, Growth, Ractopamine

The "Beta Agonist Feed Additive Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Beta Agonist Feed Additive Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)" report has been added to ResearchAndMarkets.com's offering.
  • North America to dominate the beta-agonist feed additive market by garnering nearly 77% of the global sales in 2018.
  • The increasing demand for animal meat, including ruminant and swine meat around the world, and the health benefits of beta-agonist feed additives are some of the major driving factors for the global beta-agonist feed additive market.
  • There has been increasing pressure on the livestock industry, to meet the increasing demand for meat and high-value animal protein.

Scout Bio to Feature at Morgan Stanley Animal Health Biopharma Global KOL Summit

Retrieved on: 
Thursday, June 9, 2022
Time, Biology, Elanco, Biotechnology, Research, Allergy, PETS, Pain, AAV, University, Growth, GLOBE, Patient, Diabetes, Vaccine

PHILADELPHIA, June 09, 2022 (GLOBE NEWSWIRE) -- Scout Bio , a biotechnology company revolutionizing pet medicine by delivering a pipeline of one-time gene therapies and monoclonal antibodies for major chronic pet health conditions, today announced that it will feature at Morgan Stanley Animal Health Biopharma Global KOL Summit in New York City on June 10, 2022.

Key Points: 
  • PHILADELPHIA, June 09, 2022 (GLOBE NEWSWIRE) -- Scout Bio , a biotechnology company revolutionizing pet medicine by delivering a pipeline of one-time gene therapies and monoclonal antibodies for major chronic pet health conditions, today announced that it will feature at Morgan Stanley Animal Health Biopharma Global KOL Summit in New York City on June 10, 2022.
  • Scout Bio board member Aaron Schacht will provide industry-level context for the emergence of specialty biopharmaceuticals as a key growth area for veterinary therapeutics.
  • Scout Bio is a biotechnology company revolutionizing pet medicine by delivering a pipeline of one-time gene therapies and monoclonal antibodies for major chronic pet health conditions.
  • Scout Bio has a research and development collaboration with the University of Pennsylvanias Gene Therapy Program, a leader in the field of genetic medicine research.

Vestaron Expands Leadership with Three New Hires Following $82M Series C Funding Round

Retrieved on: 
Tuesday, June 7, 2022
People, Green chemistry, VP, Leadership, HR, CFO, Elanco, Agriculture, Thermo Fisher Scientific, Initial public offering, News, Kellogg School of Management, Crop protection, Environment, Business administration, Northern Illinois University, Association of Latino Professionals in Finance and Accounting, List of life sciences, University, RTP, Master of Business Administration, Growth, GLOBE, Bachelor of Science, Acquisition, Corporate development, Culture, University of Illinois Urbana-Champaign, Controller, Renewable energy, Management, Science, Accounting, Northwestern University, Peptide

This announcement comes on the heels of recent news of Vestarons Series C funding close at $82M, an indicator of the companys commitment to continued growth, innovation, and sustainability.

Key Points: 
  • This announcement comes on the heels of recent news of Vestarons Series C funding close at $82M, an indicator of the companys commitment to continued growth, innovation, and sustainability.
  • As CFO, Juan Estupinan will work with leadership to establish financial and strategic goals, initiate investment strategies and build relationships with financial and shareholder communities.
  • Juan will have global responsibility for corporate finance, financial planning and analysis, corporate tax, investor relations, and corporate communications.
  • With their extensive experience in agriculture and beyond, Juan, Dawn and Jeff will round out our leadership and help set a course for Vestarons continued growth, said Vestaron CEO Anna Rath.

New Anthem from Seresto Could be the 2022 Song of the Summer

Retrieved on: 
Tuesday, June 7, 2022
Entertainment, Health, Consumer, Other Entertainment, Music, Pets, Veterinary, DVM, Elanco, Flea, Animal, PETS, Veterinarian, Disease, Summertime, Tick, Multimedia, Music, Interpersonal relationship, Farmer, Risk, Health, NYSE, Cat, Dog, Freedom, Instagram, ELAN, Cassette tape, Entertainment, Food

Each long-awaited summer brings a new, upbeat anthem for blaring with the car windows down or tapping your paws on the trail.

Key Points: 
  • Each long-awaited summer brings a new, upbeat anthem for blaring with the car windows down or tapping your paws on the trail.
  • View the full release here: https://www.businesswire.com/news/home/20220607005540/en/
    To celebrate a summer of protection against fleas and ticks, Seresto releases Unleash Joy and a music video featuring fan-favorite spokes pets living it up.
  • With their summer playlists set to "Unleash Joy," Seresto spokespets will be sharing how they do summer on Instagram Reels and encouraging dog or cat owners to join in the joy by sharing their pets celebration of summer fun.
  • Instagram users can find the original audio from the @SerestoUS Instagram channel and use the "Unleash Joy" anthem to share videos of their pets summer adventures with #SerestoJoinTheJoy.

Elanco to Participate in Goldman Sachs 43rd Annual Global Healthcare Conference

Retrieved on: 
Monday, June 6, 2022
Agriculture, Health, Natural Resources, Veterinary, Goldman Sachs, CFO, Elanco, Conference, Animal, PETS, Veterinarian, Disease, Interpersonal relationship, Goldman, Farmer, Health, NYSE, ELAN, Veterinary medicine, Food

Elanco Animal Health Incorporated (NYSE: ELAN) will attend the Goldman Sachs 43rd Annual Global Healthcare Conference, June 13-14, 2022.

Key Points: 
  • Elanco Animal Health Incorporated (NYSE: ELAN) will attend the Goldman Sachs 43rd Annual Global Healthcare Conference, June 13-14, 2022.
  • Todd Young, executive vice president and CFO, will participate in a fireside chat on Monday, June 13 at 6:20 p.m.
  • A live audio webcast will be available in the Events and Presentations section of Elancos investor website .
  • At Elanco, were driven by our vision of Food and Companionship Enriching life and our Elanco Healthy Purpose CSR framework all to advance the health of animals, people and the planet.